CYBIN INC.
A clinical-stage firm engineering novel psychedelic drugs for depression and anxiety.
CYBN | NYSE
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 100 KING STREET WEST, TORONTO
- Website:
- https://www.cybin.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Cybin Inc. is a clinical-stage neuropsychiatry company focused on revolutionizing mental healthcare by developing proprietary psychedelic-based therapeutics. The company engineers novel drug candidates using its drug discovery platforms and innovative delivery systems. Its scientific approach involves a proprietary deuteration process to create next-generation therapies based on well-known psychedelic compounds like psilocybin and DMT, aiming for improved therapeutic profiles. Cybin's clinical pipeline includes active programs targeting major depressive disorder (MDD) and generalized anxiety disorder (GAD). Its lead candidate, CYB003, has received FDA Breakthrough Therapy Designation for the treatment of MDD.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CYBIN INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CYBIN INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CYBIN INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
